CMS has published the FY2027 IPPS final rule, confirming the proposed DRG reclassification for CERAMENT G in the treatment of complex orthopedic infections in the US. We view the decision as supportive for BONESUPPORT, as it removes an important reimbursement hurdle for US hospitals and, furthermore, supports our sales assumptions. We expect the share to trade up 3-5% today.
LÄS MER
